Home | Video pages | E-seminar | Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease

ERA Journal Club

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial

Access the article here

Author
Hiddo Lambers Heerspink, The Netherlands

Panellists
Neeraj Dhaun, United Kingdom
Richard Haynes, United Kingdom

Moderator
Parminder Judge, United Kingdom

Monday, October 23, 2023, 5:00 – 5:45 PM (CEST)